David Ben-Avi - 16 Mar 2026 Form 3 Insider Report for Nayax Ltd. (NYAX)

Role
CTO and Co Founder, Director
Signature
David Ben Avi by: Oppenheimer Israel, as Attorney-in-fact
Issuer symbol
NYAX
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
3
Filing time
16 Mar 2026, 12:09:58 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ben-Avi David CTO and Co Founder, Director C/O NAYAX LTD., 3 ARIK EINSTEIN, HERZLIYA, ISRAEL David Ben Avi by: Oppenheimer Israel, as Attorney-in-fact 16 Mar 2026 0002000237

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NYAX Ordinary Shares 6,617,904 16 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NYAX Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 75,000 $33.71 Direct F2, F3
holding NYAX Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 75,000 $33.71 Direct F4, F5
holding NYAX Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 70,000 $33.71 Direct F6, F7
holding NYAX Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 15,605 $33.71 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were originally acquired as Founder Shares
F2 The Stock Options are Fully vested and immediately exercisable
F3 The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
F4 The Stock Options are Fully vested and immediately exercisable
F5 The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
F6 The Stock Options are Fully vested and immediately exercisable
F7 The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
F8 The Stock Options are Fully vested and immediately exercisable
F9 The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

Remarks:

This Form 3 is being filed to report the Reporting Persons beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.